STOCK TITAN

Ceribell: TPG GP A reports 3% beneficial stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) is the subject of a beneficial-ownership report by TPG GP A, LLC, James G. Coulter and Jon Winkelried. Each reports shared voting and dispositive power over the same 1,180,226 common shares, equal to 3.0% of the class; the reports list no sole voting or dispositive power.

The shares are directly held by The Rise Fund Clearthought, L.P. Coulter and Winkelried may be deemed to beneficially own the shares through their relationship to TPG GP A, but disclaim beneficial ownership except to the extent of their pecuniary interest. The 3.0% figure uses 38,835,010 shares outstanding as of October 30, 2026.

Reported beneficial ownership 1,180,226 shares Each reporting person reports the same block, directly held by The Rise Fund Clearthought, L.P.
Percent of class 3.0% Reported for each reporting person.
Shares outstanding 38,835,010 shares Common shares outstanding as of October 30, 2026; used as the denominator for the reported percentage.
beneficial ownership regulatory
"may be deemed to beneficially own the shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 1,180,226.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 1,180,226.00"
pecuniary interest financial
"except to the extent of their pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CBLL shares did the reporting persons report beneficially owning?

The three reporting persons each reported beneficial ownership of the same 1,180,226-share block, equal to 3.0% of the class. The shares are directly held by The Rise Fund Clearthought, L.P.; the reported amounts are not separate blocks to be added together.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





15678C102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,835,010 shares of Common Stock ("Common Stock") outstanding as of October 30, 2026, as reported in the Quarterly Report on Form 10-Q filed by Ceribell, Inc. (the "Issuer") with the Securities and Exchange Commission (the "Commission") on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,835,010 shares of Common Stock outstanding as of October 30, 2026, as reported in the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,835,010 shares of Common Stock outstanding as of October 30, 2026, as reported in the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on November 3, 2026.


SCHEDULE 13G



TPG GP A, LLC
Signature:/s/ Matthew White
Name/Title:Matthew White / Vice President
Date:11/16/2026
COULTER, JAMES G
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of James G. Coulter (1)
Date:11/16/2026
WINKELRIED JON
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of Jon Winkelried (2)
Date:11/16/2026

Comments accompanying signature: (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).
Exhibit Information

Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.

Keep reading